---
title: "NHS Framework Agreement, Branded Medicines for London and South of England"
ocid: "ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b.json"
source: "Contracts Finder"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2021-09-17"
---

# NHS Framework Agreement, Branded Medicines for London and South of England

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b.json)

## Summary

The procurement process involves the NHS England as the contracting authority seeking to establish a framework agreement for branded medicines in London and the South of England. The title of the tender is "NHS Framework Agreement, Branded Medicines for London and South of England," classified under the pharmaceutical products category (CPV code 33600000). The contract period runs from 1 September 2021 to 31 August 2023, with options for extensions. The procurement method is an open procedure, with a total contract value estimated at £441,994,547 and key dates indicating that the tender period ended on 4 June 2021.

This tender presents significant opportunities for businesses engaged in the pharmaceutical sector, particularly small to medium-sized enterprises (SMEs) well-positioned to compete for contracts in supplying branded medicines. Given the extensive scope of the framework covering various regions, including the East Midlands, London, and the North West, suppliers that can demonstrate experience in pharmaceutical distribution and compliance with NHS regulations will be well-suited for participation. The framework can help SMEs expand their market reach through collaborative engagements within a highly regulated and lucrative healthcare environment.

## Notice

NHS Framework Agreement, Branded Medicines for London and South of England Offer reference number: CM/PHR/20/5598 FIND A TENDER (FTS) Reference number: FTS-002229 CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B. Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A. Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche. Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions - Bevacizumab Period of Framework: 1 September 2021 to 28 February 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/80bd00f1-7cd9-4d19-804e-84505b1f615d |
| Notice type | Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure (above threshold) |
| Tender suitability | SME |
| Awardee scale | Large, SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 17 Sep 2021 |
| Submission deadline | 4 Jun 2021 |
| Future notice date | Not specified |
| Award date | 18 Aug 2021 |
| Contract period | 31 Aug 2021 - 31 Aug 2023 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £441,994,547 |
| Lots value | Not specified |
| Awards value | £558,521,926 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | RUNCORN |
| Post town | Warrington |
| Postcode | WA7 2ES |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD7 Merseyside |
| ITL 3 | TLD71 East Merseyside |
| Local authority | Halton |
| Electoral ward | Halton Lea |
| Westminster constituency | Runcorn and Helsby |
| Delivery location | TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England) |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 42 |
| Supplier names | ACCORD-UK; ALLERGAN; AMGEN; ASTRAZENECA; AVENTIS PHARMA LTD T/A SANOFI; BAYER; BIOGEN; BRISTOL MYERS SQUIBB; CELLTRION HEALTHCARE UNITED KINGDOM; CHUGAI; CST PHARMA; DAIICHI SANKYO; DR.REDDY'S LABORATORIES (UK; ELI LILLY; FERRING PHARMACEUTICALS; GEDEON RICHTER; GILEAD SCIENCES; IPSEN; JANSSEN-CILAG; MERCK SERONO; MERCK SHARPE & DOHME (UK; MERZ; MORNINGSIDE PHARMAEUTICALS; MYLAN; NAPP PHARMACEUTICALS; NOVO NORDISK; ORGANON PHARMACEUTICALS; PFIZER; PHARMACOSMOS; PROFILE PHARMA; ROCHE PRODUCTS; SANDOZ; SOBI (SWEDISH ORPHAN BIOVITRUM; TAKEDA; TECHDOW PHARMA ENGLAND; TETRIS PHARMA LTS; TEVA; THORNTON AND ROSS; UCB; UL GLOBAL PHARMA; VIFOR PHARMA; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 17 Sep 2021 at 15:11 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/80bd00f1-7cd9-4d19-804e-84505b1f615d
- 17 Sep 2021 at 15:08 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/87462943-eaf5-48e4-8e64-f87426d9c24c

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/80bd00f1-7cd9-4d19-804e-84505b1f615d
  17th September 2021 - Awarded contract notice on Contracts Finder
- https://www.contractsfinder.service.gov.uk/Notice/87462943-eaf5-48e4-8e64-f87426d9c24c
  17th September 2021 - Awarded contract notice on Contracts Finder
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj4/e4859nDqBoSEEAiTSAYCf.h8.XseZEZGtK.tS1W6BIk
  Parties Awarded to Framework
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVio/gHNH8g8.YgKa2hmBgMeIkTCt98GDQwZSf8Q0we4OOHw
  03. Framework Agreement and Terms and Conditions -CM_PHR_20_5598 NHS Framework Agreement, Branded Medicines for London and South of England Template
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj3/F2uf5OXU_ZCY1h0I.EL_RTPdm8OpkPOaQdyba99QRrQ
  CM_PHR_20_5598_01 - NHS Framework LONDON Branded Medicines - Tranche B Transparency Award Schedule
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVit/WA7wOa57AKOMfFmG37.jte257TrDW38H._iXppUJOmE
  CM_PHR_20_5598_06 - NHS Framework Midlands & East and NofE - Bevacizumab Transparency Award Schedule
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj2/no32CQoP7LDSZpTThhQmRG6N4LWIyECrHCy24M95qkE
  CM _PHR_20_5598_03 - NHS Framework SOUTH of England Tranche A Transparency Award Schedule
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVis/kL0N6R5GgfobI40X.C2zFegh6.2h6aF.ZKMLfZxAvtk
  CM_PHR_20_5598_04- NHS Framework SOUTH of England - Tranche B. Transparency Award Schedule
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVix/_0ogC52eXQSjNBdxTY5Jir5zL8U9vtCjHx4oppSM6x0
  CM_PHR_20_5598_02 - NHS Framework LONDON Branded Medicines - Annual Tranche Transparency Award Schedule
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVin/epK1hXNyTh5O9gdN.Fkye6ESV54MJt_kgK5srRD4EyM
  CM_PHR_20_5598_05 - NHS Framework SOUTH of England Annual Tranche Transparency Award Schedule

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b.json.